Free Trial

Journey Medical (DERM) Institutional Ownership

Journey Medical logo
$7.06 +0.47 (+7.06%)
As of 01:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Journey Medical (NASDAQ:DERM)

Current
Institutional Ownership
Percentage
7.25%
Number of
Institutional Buyers
(last 12 months)
14
Total
Institutional Inflows
(last 12 months)
$11.57M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$1.32M
Get DERM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Journey Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

DERM Institutional Buying and Selling by Quarter

Remove Ads

Journey Medical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Tang Capital Management LLC1,725,569$6.75M0.4%N/A8.260%
2/17/2025Cetera Investment Advisers13,839$54K0.0%+21.8%0.066%
2/17/2025Citadel Advisors LLC44,568$174K0.0%N/A0.213%
2/14/2025Kovitz Investment Group Partners LLC24,710$97K0.0%+112.9%0.118%
2/14/2025Integrated Wealth Concepts LLC58,850$230K0.0%-4.1%0.282%
2/14/2025Dimensional Fund Advisors LP20,455$80K0.0%N/A0.098%
2/13/2025Renaissance Technologies LLC236,000$923K0.0%-12.0%1.130%
2/13/2025Titleist Asset Management LLC10,900$43K0.0%-23.5%0.052%
2/13/2025Envestnet Asset Management Inc.103,557$405K0.0%-5.5%0.496%
1/29/2025Gladstone Institutional Advisory LLC29,981$117K0.0%-10.5%0.144%
11/25/2024PVG Asset Management Corp167,545$947K3.8%+5.7%0.802%
11/16/2024Geode Capital Management LLC108,435$613K0.0%+13.5%0.523%
11/15/2024Kovitz Investment Group Partners LLC11,605$66K0.0%N/A0.056%
11/14/2024Walleye Capital LLC23,098$131K0.0%-63.7%0.111%
11/12/2024Nwam LLC10,430$59K0.0%N/A0.050%
11/1/2024Atria Investments Inc44,397$251K0.0%-19.8%0.214%
10/30/2024Rosalind Advisors Inc.105,917$598K0.4%-7.2%0.529%
10/11/2024ORG Wealth Partners LLC19,519$110K0.0%N/A0.094%
8/22/2024PVG Asset Management Corp158,540$894K3.5%N/A0.792%
8/9/2024Renaissance Technologies LLC264,025$1.49M0.0%-2.4%1.319%
8/8/2024TMD Wealth Management LLC11,605$65K0.0%N/A0.058%
8/6/2024Acadian Asset Management LLC94,404$531K0.0%-57.6%0.472%
7/26/2024Cambridge Investment Research Advisors Inc.294,950$1.66M0.0%N/A1.474%
7/12/2024Rosalind Advisors Inc.114,132$644K0.5%N/A0.570%
5/14/2024Heron Bay Capital Management33,669$124K0.0%N/A0.169%
5/10/2024Acadian Asset Management LLC222,663$817K0.0%+687.5%1.117%
5/10/2024Perkins Capital Management Inc.22,000$81K0.1%-31.3%0.110%
5/10/2024Nwam LLC11,820$41K0.0%N/A0.059%
(Data available from 1/1/2016 forward)

Remove Ads

DERM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DERM shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Journey Medical. The most heavily invested institutionals were Tang Capital Management LLC ($6.75M), Cambridge Investment Research Advisors Inc. ($1.66M), PVG Asset Management Corp ($947K), Renaissance Technologies LLC ($923K), Geode Capital Management LLC ($613K), Rosalind Advisors Inc. ($598K), and Acadian Asset Management LLC ($531K).Learn more on DERM's institutional investors.

What percentage of Journey Medical stock is owned by institutional investors?

7.25% of Journey Medical stock is owned by institutional investors. Learn more on DERM's institutional investor holdings.

Which institutional investors have been buying Journey Medical stock?

Of the 14 institutional investors that purchased Journey Medical stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($1.73M), Cambridge Investment Research Advisors Inc. ($294.95K), Acadian Asset Management LLC ($194.39K), PVG Asset Management Corp ($167.55K), Rosalind Advisors Inc. ($114.13K), Citadel Advisors LLC ($44.57K), and Heron Bay Capital Management ($33.67K).

How much institutional buying is happening at Journey Medical?

Institutional investors have bought a total of 2,688,721 shares in the last 24 months. This purchase volume represents approximately $11.57M in transactions.

Which Journey Medical major shareholders have been selling company stock?

Of the 10 institutional investors that sold Journey Medical stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Acadian Asset Management LLC ($128.26K), Walleye Capital LLC ($40.48K), Renaissance Technologies LLC ($38.78K), Atria Investments Inc ($10.94K), Perkins Capital Management Inc. ($10K), Rosalind Advisors Inc. ($8.22K), and Envestnet Asset Management Inc. ($6.03K).

How much institutional selling is happening at Journey Medical?

Institutional investors have sold a total of 252,049 shares in the last 24 months. This volume of shares sold represents approximately $1.32M in transactions.



This page (NASDAQ:DERM) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners